litlas
ログインアカウント作成

Peter Hersey

1973–2024 年に発表

145
論文数
34,649
被引用数
93
h 指数
144
i10 指数

被引用数

Peter Hersey の年別被引用数1974 年: 被引用 3 件1975 年: 被引用 2 件1976 年: 被引用 4 件1977 年: 被引用 5 件1978 年: 被引用 4 件1979 年: 被引用 2 件1980 年: 被引用 4 件1981 年: 被引用 6 件1982 年: 被引用 10 件1983 年: 被引用 8 件1984 年: 被引用 8 件1985 年: 被引用 13 件1986 年: 被引用 12 件1987 年: 被引用 16 件1988 年: 被引用 8 件1989 年: 被引用 18 件1990 年: 被引用 21 件1991 年: 被引用 6 件1992 年: 被引用 12 件1993 年: 被引用 12 件1994 年: 被引用 12 件1995 年: 被引用 25 件1996 年: 被引用 29 件1997 年: 被引用 31 件1998 年: 被引用 35 件1999 年: 被引用 74 件2000 年: 被引用 90 件2001 年: 被引用 135 件2002 年: 被引用 100 件2003 年: 被引用 151 件2004 年: 被引用 140 件2005 年: 被引用 124 件2006 年: 被引用 104 件2007 年: 被引用 152 件2008 年: 被引用 171 件2009 年: 被引用 140 件2010 年: 被引用 153 件2011 年: 被引用 166 件2012 年: 被引用 266 件2013 年: 被引用 508 件2014 年: 被引用 597 件2015 年: 被引用 645 件2016 年: 被引用 477 件2017 年: 被引用 565 件2018 年: 被引用 544 件2019 年: 被引用 1,434 件2020 年: 被引用 1,362 件2021 年: 被引用 1,180 件2022 年: 被引用 936 件2023 年: 被引用 583 件2024 年: 被引用 807 件2025 年: 被引用 340 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,386 件、この内訳の 28.3%中国: 引用元論文 1,490 件、この内訳の 9.6%オーストラリア: 引用元論文 968 件、この内訳の 6.3%イギリス: 引用元論文 907 件、この内訳の 5.9%ドイツ: 引用元論文 835 件、この内訳の 5.4%イタリア: 引用元論文 823 件、この内訳の 5.3%フランス: 引用元論文 708 件、この内訳の 4.6%オランダ: 引用元論文 482 件、この内訳の 3.1%カナダ: 引用元論文 459 件、この内訳の 3%日本: 引用元論文 426 件、この内訳の 2.7%スイス: 引用元論文 390 件、この内訳の 2.5%スペイン: 引用元論文 389 件、この内訳の 2.5%
0%28.3%その他 20.8%

機関

分野

  • Medicine54.3%
  • Biochemistry, Genetics and Molecular Biology32.7%
  • Immunology and Microbiology9.7%
  • Engineering0.8%
  • Computer Science0.4%
  • Neuroscience0.4%
  • その他1.7%

トピック

  • Cancer Immunotherapy and Biomarkers11.8%
  • Immunotherapy and Immune Responses7%
  • Melanoma and MAPK Pathways6.8%
  • CAR-T cell therapy research5.2%
  • Cutaneous Melanoma Detection and Management5.2%
  • Immune Cell Function and Interaction3.2%
  • その他60.8%

共著者

全論文

検索で開く
  1. Whole-genome landscapes of major melanoma subtypes

    著者: Nicholas K. Hayward, James S. Wilmott, Nicola Waddell, Peter A. Johansson, Matthew A. Field, Kátia Nones, Ann‐Marie Patch, Hojabr Kakavand, Ludmil B. Alexandrov, Hazel Burke, Valerie Jakrot, Stephen H. Kazakoff, Oliver Holmes, Conrad Leonard, Radhakrishnan Sabarinathan, Loris Mularoni, Scott Wood, Qinying Xu, Nick M. Waddell, Varsha Tembe, Gulietta M. Pupo, Ricardo De Paoli‐Iseppi, Ricardo E. Vilain, Ping Shang, Loretta M. S. Lau, Rebecca A. Dagg, Sarah‐Jane Schramm, Antonia L. Pritchard, Ken Dutton‐Regester, Felicity Newell, Anna Fitzgerald, Catherine A. Shang, Sean M. Grimmond, Hilda A. Pickett, Jean Yang, Jonathan R. Stretch, Andreas Behren, Richard Kefford, Peter Hersey, Georgina V. Long, Jonathan Cebon, Mark Shackleton, Andrew J. Spillane, Robyn P.M. Saw, Núria López-Bigas, John V. Pearson, John F. Thompson, Richard A. Scolyer, Graham J. Mann - Nature 2017 被引用: 1,522

  2. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

    著者: Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen‐Jen Hwu, Richard Kefford, Jedd D. Wolchok, Peter Hersey, Richard W. Joseph, Jeffrey S. Weber, Roxana Dronca, Tara C. Mitchell, Amita Patnaik, Hassane M. Zarour, Anthony M. Joshua, Qi Zhao, E. Jensen, S. Ahsan, Nageatte Ibrahim, Antoni Ribas - Annals of Oncology 2019 被引用: 944

  3. Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

    著者: Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd D. Wolchok, Peter Hersey, Richard W. Joseph, Jeffrey S. Weber, Roxana Dronca, Tara C. Gangadhar, Amita Patnaik, Hassane M. Zarour, Anthony M. Joshua, Kevin Gergich, Jeroen Elassaiss‐Schaap, Alain P. Algazi, Christine Mateus, Peter D. Boasberg, Paul C. Tumeh, Bartosz Chmielowski, Scot Ebbinghaus, Xiaoyun Li, Sunyu Kang, Antoni Ribas - New England Journal of Medicine 2013 被引用: 3,395

  4. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

    著者: Keith T. Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev Demidov, Jessica C. Hassel, Piotr Rutkowski, Peter Mohr, Reinhard Dummer, Uwe Trefzer, James Larkin, Jochen Utikal, Brigitte Dréno, Marta Nyakas, Mark R. Middleton, Jürgen C. Becker, Michelle Casey, Laurie Sherman, Frank Wu, Danièle Ouellet, Anne‐Marie Martin, Kiran Klaus Patel, Dirk Schadendorf - New England Journal of Medicine 2012 被引用: 2,141

  5. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

    著者: Antoni Ribas, Omid Hamid, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok, Richard Kefford, Anthony M. Joshua, Amita Patnaik, Wen-Jen Hwu, Jeffrey S. Weber, Tara C. Gangadhar, Peter Hersey, Roxana Dronca, Richard W. Joseph, Hassane M. Zarour, Bartosz Chmielowski, Donald P. Lawrence, Alain P. Algazi, Naiyer A. Rizvi, Brianna Hoffner, Christine Mateus, Kevin Gergich, Jill A. Lindia, Maxine Giannotti, Xiaoyun Li, Scot Ebbinghaus, Soonmo Peter Kang, Caroline Robert - JAMA 2016 被引用: 1,062

  6. CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

    著者: Jarem Edwards, James S. Wilmott, Jason Madore, Tuba N. Gide, Camelia Quek, Annie Tasker, Angela L. Ferguson, Jinbiao Chen, Rehana Hewavisenti, Peter Hersey, Thomas Gebhardt, Wolfgang Weninger, Warwick J. Britton, Robyn P.M. Saw, John F. Thompson, Alexander M. Menzies, Georgina V. Long, Richard A. Scolyer, Umaimainthan Palendira - Clinical Cancer Research 2018 被引用: 441

  7. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    著者: Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci ほか 32 名 - The Lancet Oncology 2021 被引用: 389

  8. Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma

    著者: Adil Daud, Jedd D. Wolchok, Caroline Robert, Wen-Jen Hwu, Jeffrey S. Weber, Antoni Ribas, F. Stephen Hodi, Anthony M. Joshua, Richard Kefford, Peter Hersey, Richard W. Joseph, Tara C. Gangadhar, Roxana Dronca, Amita Patnaik, Hassane M. Zarour, Charlotte Roach, Grant Toland, Jared Lunceford, Xiaoyun Li, Kenneth Emancipator, Marisa Dolled‐Filhart, Sunyu Kang, Scot Ebbinghaus, Omid Hamid - Journal of Clinical Oncology 2016 被引用: 678

  9. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    著者: Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W.J.M. Wouters, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Carlo Riccardo Rossi, Rogerio I. Neves, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Douglas B. Johnson, Patrick Terheyden, Adam C. Berger, Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 被引用: 1,385

  10. Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

    著者: Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter, René González, Anna C. Pavlick, Jeffrey S. Weber, Grant A. McArthur, Thomas E. Hutson, Stergios J. Moschos, Keith T. Flaherty, Peter Hersey, Richard Kefford, Donald P. Lawrence, Igor Puzanov, Karl D. Lewis, Ravi K. Amaravadi, Bartosz Chmielowski, H. Jeffrey Lawrence, Yu Shyr, Fei Ye, Jiang Li, K. B. Nolop, Richard J. Lee, Andrew K. Joe, Antoni Ribas - New England Journal of Medicine 2012 被引用: 2,148

  11. Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

    著者: Caroline Robert, Antoni Ribas, Omid Hamid, Adil Daud, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Tara C. Gangadhar, Richard W. Joseph, Roxana Dronca, Amita Patnaik, Hassane M. Zarour, Richard Kefford, Peter Hersey, Jin Zhang, James R. Anderson, Scott J. Diede, Scot Ebbinghaus, F. Stephen Hodi - Journal of Clinical Oncology 2017 被引用: 482

  12. Guidelines for the use of platelet transfusions

    著者: Lise J Estcourt, Janet Birchall, Shubha Allard, Stephen J. Bassey, Peter Hersey, Jonathan P. Kerr, Andrew Mumford, Simon Stanworth, Hazel Tinegate - British Journal of Haematology 2016 被引用: 626

  13. Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

    著者: Caroline Robert, Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok, Tara C. Mitchell, Peter Hersey, Roxana Dronca, Richard W. Joseph, C. Boutros, Le Min, Georgina V. Long, Jacob Schachter, Igor Puzanov, Reinhard Dummer, Jianxin Lin, Nageatte Ibrahim, Scott J. Diede, Matteo S. Carlino, Anthony M. Joshua - European Journal of Cancer 2020 被引用: 100

  14. Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

    著者: James S. Wilmott, Georgina V. Long, Julie R. Howle, Lauren E. Haydu, Raghwa Sharma, John F. Thompson, Richard Kefford, Peter Hersey, Richard A. Scolyer - Clinical Cancer Research 2011 被引用: 650

  15. Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

    著者: Richard W. Joseph, Jeroen Elassaiss‐Schaap, Richard Kefford, Wen-Jen Hwu, Jedd D. Wolchok, Anthony M. Joshua, Antoni Ribas, F. Stephen Hodi, Omid Hamid, Caroline Robert, Adil Daud, Roxana Dronca, Peter Hersey, Jeffrey S. Weber, Amita Patnaik, Dinesh P. de Alwis, Andrea Perrone, Jin Zhang, Soonmo Peter Kang, Scot Ebbinghaus, Keaven M. Anderson, Tara C. Gangadhar - Clinical Cancer Research 2018 被引用: 309

  16. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Brigitte Dréno, John F Thompson, B. Mark Smithers, Mario Santinami, Thomas Jouary, Ralf Gutzmer, E. Levchenko, Piotr Rutkowski, Jean-Jacques Grob, S.I. Korovin, Kamil Drucis, Florent Grange, L. Machet, Peter Hersey, Ivana Krajsová, Alessandro Testori, Robert M. Conry, B. Guillot, Wim H.J. Kruit, Lev Demidov, John A. Thompson, Igor Bondarenko, Jarosław Jaroszek, Susana Puig, Gabriela Cinat, Axel Hauschild, Jelle J. Goeman, Hans C. van Houwelingen, Fernando Ulloa-Montoya, Andrea Callegaro, Benjamin Dizier, Bart Spiessens, Muriel Debois, Vincent Brichard, Jamila Louahed, Patrick Therasse, C. Debruyne, John M. Kirkwood - The Lancet Oncology 2018 被引用: 198

  17. Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

    著者: C. Owen, Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan, Joanna Mangana, Victoria Atkinson, Farzana Y. Zaman, Arissa Young, Christoph Höeller, Peter Hersey, R. Dummer, Muhammad A. Khattak, Michael Millward, Sapna P. Patel, Andrew Haydon, Douglas B. Johnson, Serigne Lo, Christian U. Blank, Shahneen Sandhu, Matteo S. Carlino, James Larkin, Alexander M. Menzies, Georgina V. Long - Annals of Oncology 2020 被引用: 110

  18. Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

    著者: Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher, Jessamy Tiffen, Helen Rizos, Peter Hersey - PLoS ONE 2015 被引用: 222

  19. Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy

    著者: Abdullah Al Emran, Aniruddha Chatterjee, Euan J. Rodger, Jessamy Tiffen, Stuart Gallagher, Michael R. Eccles, Peter Hersey - Trends in Immunology 2019 被引用: 215

  20. Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab

    著者: F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jeffrey S. Weber, Adil Daud, Omid Hamid, Amita Patnaik, Antoni Ribas, Caroline Robert, Tara C. Gangadhar, Anthony M. Joshua, Peter Hersey, Roxana Dronca, Richard W. Joseph, Darcy A. Hille, Dahai Xue, Xiaoyun Li, Sunyu Kang, Scot Ebbinghaus, Andrea Perrone, Jedd D. Wolchok - Journal of Clinical Oncology 2016 被引用: 751

  21. PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials

    著者: Jason Madore, Ricardo E. Vilain, Alexander M. Menzies, Hojabr Kakavand, James S. Wilmott, Jessica Hyman, Jennifer H. Yearley, Richard Kefford, John F. Thompson, Georgina V. Long, Peter Hersey, Richard A. Scolyer - Pigment Cell & Melanoma Research 2014 被引用: 392

  22. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma

    著者: Peter Hersey, Jeffrey A. Sosman, Steven O’Day, Jon Richards, Agop Y. Bedikian, René González, William H. Sharfman, Robert Weber, Theodore F. Logan, Manuela Buzoianu, Luz Hammershaimb, John M. Kirkwood - Cancer 2010 被引用: 186

  23. Systemic Therapy of Malignant Human Melanoma Tumors by a Common Cold-Producing Enterovirus, Coxsackievirus A21

    著者: Darren R. Shafren, Gough G. Au, Tam Nguyen, Nicole G. Newcombe, Erin S. Haley, Leone Beagley, Emil Johansson, Peter Hersey, Richard D. Barry - Clinical Cancer Research 2004 被引用: 155

  24. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

    著者: Andrew Bottomley, Corneel Coens, Justyna Mierzynska, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, Susana Puig, Paolo A. Ascierto, James Larkin, Paul Lorigan, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh, Jean‐Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C. J. van Akkooi, Clemens Krepler, Nageatte Ibrahim, Sandrine Marréaud, Michal Kiciński, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Thierry Lesimple, Michele Maio, Gerald P. Linette, Laurent Mortier, Inge Marie Svane, Jacob Schachter, Michael P. Brown, Peter Hersey, Catherine Barrow, Ragini R. Kudchadkar, Caroline Dutriaux, Xinni Song, Pietro Quaglino, Paola Queirolo, Friedegund Meier, Daniil Stroyakovskiy, B. Guillot, Pablo L. Ortiz‐Romero, Lars Bastholt, Claus Garbe, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Carmen Loquai, Frank Meiß, Vanna Chiarion‐Sileni, Gil Bar‐Sela, Bernard M. Fitzharris, Philippe Saïag, Jean‐Philippe Arnault, Jan‐Christoph Simon, Rosalie Stephens, Jean‐François Baurain, Célèste Lebbé, P. Combemale, Reinhard Dummer, Axel Hauschild, Phillip Parente, Naoya Yamazaki, Mohammed Milhem, M.‐T. Leccia, L. Geoffrois, Lutz Kretschmer, Elaine Dunwoodie, John Walker, Michal Lotem, Daniel Hendler, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Marcin Dzienis, Geke A.P. Hospers, Marco Siano, Jessica C. Hassel, Philippa Corrie, Maria-Jose Passos, Max Levin, Christoph Höeller, L. Machet, Sigrun Hallmeyer, Ashita Waterston, V. Descamps, Felix Kiecker, Maureen J.B. Aarts, Henrik Schmidt ほか 34 名 - The Lancet Oncology 2021 被引用: 72